Insulet Corporation
PODD
$228.17
-$0.46-0.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 783.80M | 706.20M | 649.10M | 569.00M | 597.50M |
| Total Other Revenue | -- | 100.00K | -- | -- | -- |
| Total Revenue | 783.80M | 706.30M | 649.10M | 569.00M | 597.50M |
| Cost of Revenue | 215.20M | 196.20M | 196.90M | 160.00M | 180.10M |
| Gross Profit | 568.60M | 510.10M | 452.20M | 409.00M | 417.40M |
| SG&A Expenses | 331.40M | 315.20M | 257.70M | 260.60M | 260.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 637.50M | 588.60M | 528.00M | 480.20M | 501.60M |
| Operating Income | 146.30M | 117.70M | 121.10M | 88.80M | 95.90M |
| Income Before Tax | 140.10M | 122.80M | 28.40M | 48.10M | 111.40M |
| Income Tax Expenses | 38.50M | 35.20M | 5.90M | 12.70M | 10.70M |
| Earnings from Continuing Operations | 101.60M | 87.60M | 22.50M | 35.40M | 100.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 101.60M | 87.60M | 22.50M | 35.40M | 100.70M |
| EBIT | 146.30M | 117.70M | 121.10M | 88.80M | 95.90M |
| EBITDA | 170.70M | 139.70M | 143.40M | 110.50M | 117.40M |
| EPS Basic | 1.44 | 1.24 | 0.32 | 0.50 | 1.44 |
| Normalized Basic EPS | 1.24 | 1.09 | 1.00 | 0.80 | 0.87 |
| EPS Diluted | 1.44 | 1.24 | 0.32 | 0.50 | 1.39 |
| Normalized Diluted EPS | 1.24 | 1.09 | 1.00 | 0.76 | 0.83 |
| Average Basic Shares Outstanding | 70.36M | 70.37M | 70.39M | 70.27M | 70.16M |
| Average Diluted Shares Outstanding | 70.67M | 70.66M | 70.65M | 74.11M | 74.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |